A Randomized, Open-label Study to Evaluate the Effect of Daprodustat on Blood Pressure in Subjects With Anemia Associated With Chronic Kidney Disease on Hemodialysis Switched From a Stable Dose of an Erythropoiesis-stimulating Agent
Phase of Trial: Phase II
Latest Information Update: 08 Apr 2018
At a glance
- Drugs Daprodustat (Primary) ; Epoetin alfa
- Indications Anaemia; Hypertension
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 16 Mar 2018 Planned End Date changed from 20 Jun 2018 to 13 Feb 2019.
- 16 Mar 2018 Planned primary completion date changed from 21 May 2018 to 13 Feb 2019.
- 18 Aug 2017 Status changed from not yet recruiting to recruiting.